Elaine C DeFreitas

Title: Elaine C DeFreitas: Innovator in Immunology

Introduction

Elaine C DeFreitas is a prominent inventor based in Villanova, PA (US). She has made significant contributions to the field of immunology, particularly through her innovative patents. With a total of 3 patents, her work has had a profound impact on medical research and treatment methodologies.

Latest Patents

Among her latest patents is the development of a lymphokine that can activate and stimulate CD3.sup.+, CD4.sup.+ T cells, as well as Sezary leukemic T cells. This lymphokine can be obtained from mitogen-stimulated peripheral blood mononuclear cells or the urine of Sezary Syndrome patients. Additionally, it is known to upregulate interleukin-2 receptors. Another notable patent involves a method for inducing an immunological response to solid tumors using anti-idiotype antibodies that present an internal image of a tumor or antigen to patients. This innovation includes the provision of monoclonal anti-idiotype antibodies and immortal B lymphocytes that produce them.

Career Highlights

Elaine has worked at The Wistar Institute, where she has been involved in groundbreaking research. Her career is marked by her dedication to advancing the understanding of immune responses and developing new therapeutic strategies.

Collaborations

Throughout her career, Elaine has collaborated with notable figures in the field, including Hilary Koprowski and Dorothee Herlyn. These partnerships have further enriched her research and contributions to immunology.

Conclusion

Elaine C DeFreitas stands out as an influential inventor in the realm of immunology, with her patents paving the way for innovative treatments and therapies. Her work continues to inspire advancements in medical science.